Philips Receives FDA Approval for Revolutionary AI Technology

Philips AI-powered MRI scanners receive FDA approval

Artificial intelligence software accelerates the scanning process.

Philips has received FDA clearance for its artificial-intelligence MR platform, which is used to detect cancerous tumours in the head or neck.

FDA approval for AI technology

Philips announced that FDA cleared its AI-enabled radiotherapy. The clearance is also known as 510(k), and requires that device manufacturers register with FDA, and inform them of their intention to market a device 90 days before the actual launch date.